• BARKER, E.L., WESTPHAL, R.S., SCHMIDT, D. & SANDERS-BUSH, E. (1994). Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity receptor ligands. J. Biol. Chem., 269, 1168711690.
  • BOND, R.A., LEFF, P., JOHNSON, T.D., MILANO, C.A., ROCKMAN, H.A., MCMINN, T.R., APPARSUNDARAM, S., HYEK, M.F., KENAKIN, T., ALLEN, L.F. & LEFKOWITZ, R.J. (1995). Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor. Nature, 374, 272276.
  • CHIDIAC, P., HEBERT, T.E., VALIQUETTE, M., DENNIS, M. & BOUVIER, M. (1994). Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol., 45, 490499.
  • COSTA, T., OGINO, Y., MUNSON, P.J., ONARAN, H.O. & RODBARD, D. (1992). Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol., 41, 549560.
  • GARCÍA-SÁINZ, J.A. & TORRES-PADILLA, M.E. (1999). Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing alpha1d-adrenoceptors. Febs Lett, 443, 27781.
  • GRAHAM, R.M., PEREZ, D.M., HWA, J. & PIASCIK, M.T. (1996). α1-adrenergic receptor subtypes Molecular structure, function, and signaling. Circ. Res., 78, 737749.
  • HWA, J. & PEREZ, D.M. (1996). The unique nature of the serine interactions for α1-adrenergic receptor agonist binding and activation. J. Biol. Chem., 271, 63226327.
  • KENAKIN, T. (1996). The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev, 48, 413463.
  • KJELSBERG, M.A., COTECCHIA, S., OSTROWSKI, J., CARON, M.G. & LEFKOWITZ, R.J. (1992). Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem., 267, 14301433.
  • KUNKEL, T.A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. U.S.A., 82, 488492.
  • LEE, T.W., COTECCHIA, S. & MILLIGAN, G. (1997). Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster α1B-adrenoceptor by ligands that act as inverse agonists. Biochem. J., 325, 733739.
  • LEFKOWITZ, R.J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci., 14, 303307.
  • MACEWAN, D.J. & MILLIGAN, G. (1996). Inverse agonist-induced up-regulation of the human β2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells. Mol. Pharmacol., 50, 14791486.
  • MEWES, T., DUTZ, S., RAVENS, U. & JAKOBS, K. (1993). Activation of calcium currents in cardiac myocytes by empty β-adrenoreceptors. Circulation, 88, 29162922.
  • MILANO, C.A., DOLBER, P.C., ROCKMAN, H.A., BOND, R.A., VENABLE, M.E., ALLEN, L.H. & LEFKOWITZ, R.J. (1994). Myocardial expression of a constitutively active α1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A., 91, 1010910113.
  • MINNEMAN, K.P., THEROUX, T.L., HOLLINGER, S., HAN, C. & ESBENSHADE, T.A. (1994). Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol. Pharmacol., 46, 929936.
  • MURAMATSU, I., MURATA, S., ISAKA, M., PIAO, H.L., ZHU, J., SUZUKI, F., MIYAMOTO, S., OSHITA, M., WATANABE, Y. & TANIGUCHI, T. (1998). Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sciences, 62, 14611465.
  • NEWMAN-TANCREDI, A., CONTE, C., CHAPUT, C., SPEDDING, M. & MILLAN, M. (1997). Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist WAY 100,635. Br. J. Pharmacol., 120, 737739.
  • PARMA, J., DUPREZ, L., VAN SANDE, J., COCHAUX, P., GERVY, C., MOCKEL, J., DUMONT, J. & VASSART, G. (1993). Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature, 365, 649651.
  • REN, Q., KUROSE, H., LEFKOWITZ, R.J. & COTECCHIA, S. (1993). Constitutively active mutants of the α2-adrenergic receptor. J. Biol. Chem., 268, 1648316487.
  • ROSSIER, O., ABUIN, L., FANELLI, F., LEONARDI, A. & COTECCHIA, S. (1999). Inverse agonism and neutral antagonism at α1a- and α1b-adrenergic receptor subtypes. Mol. Pharmacol., 56, 858866.
  • SAMAMA, P., COTECCHIA, S., COSTA, T. & LEFKOWITZ, R.J. (1993). A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem., 268, 46254636.
  • SHRYOCK, J.C., OZECK, M.J. & BELARDINELLI, L. (1998). Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol. Pharmacol., 53, 886893.
  • SMIT, M.J., LEURS, R., ALEWIJNSE, A.E., BLAUW, J., VAN NIEUW AMERONGEN, G.P., VAN DE VREDE, Y., ROOVERS, E. & TIMMERMAN, H. (1996). Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc. Natl. Acad. Sci. U.S.A., 93, 68026807.
  • SUZUKI, F., TANIGUCHI, T., TAKAUJI, R., MURATA, S. & MURAMATSU, I. (2000). Splice isoforms of α1a-adrenoceptor in rabbit. Br. J. Pharmacol., 129, 15691576.
  • TANIGUCHI, T., INAGAKI, R., MURATA, S., AKIBA, I. & MURAMATSU, I. (1999). Microphysiometric analysis of human α-1a adrenoceptor expressed in Chinese hamster ovary cells. Br. J. Pharmacol., 127, 962968.